Zynerba Press Releases

15 Apr 21 Zynerba Pharmaceuticals Announces the Acceptance of Two Posters at the Society of Biological Psychiatry 2021 Virtual Meeting

6 Apr 21 Zynerba Pharmaceuticals to Present at the Needham Virtual Healthcare Conference

10 Mar 21 Zynerba Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Highlights

4 Mar 21 Zynerba Pharmaceuticals to Participate in the 33rd Annual ROTH Conference

4 Jan 21 Zynerba Pharmaceuticals to Present at Two January Virtual Investor Conferences

17 Dec 20 Zynerba Pharmaceuticals Provides Regulatory Update on Zygel™ in Fragile X Syndrome

4 Dec 20 Zynerba Pharmaceuticals Presents New Data in Two Posters at the 2020 Annual Meeting of the American Epilepsy Society (AES)

23 Nov 20 Zynerba Pharmaceuticals Announces the Acceptance of Two Posters at the 2020 Virtual Annual Meeting of the American Epilepsy Society (AES)

9 Nov 20 Zynerba Pharmaceuticals Reports Third Quarter 2020 Financial Results and Operational Highlights

15 Oct 20 Zynerba Pharmaceuticals Presents Data Supporting FMR1 Methylation Status as a Correlate to Fragile X Syndrome Severity at the Virtual Joint 16th International Child Neurology Congress (ICNC) & 49th Annual Child Neurology Society (CNS) Meeting